G6PD Deficiency Clinical Trial
Official title:
Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise
The purpose of this study is to investigate the effects of N-acetyl Cystein (NAC) supplementation on redox status, physiological and biochemical parameters in G6PD deficient individuals after acute exercise.
In a randomized double-blind, crossover design, 12 adult volunteers with G6PD deficiency of both sexes will be supplemented with either 10 mg/kg of NAC (experimental condition - EC) or placebo (control condition - CC) every day for 4 weeks. Before intervention, all participants will be informed about the study protocol, fill a medical history questionnaire and sign an informed consent form. Moreover, measurements of anthropometric characteristics and physiological parameters, as well as a VO2max test will be performed. Participants will perform 4 trials of exercise (70% VO2max for 45min and 90% till exhaustion) before and after each condition. Blood samples will be collected before, immediately after and 1 hour after exercise. Moreover, measurements of anthropometric characteristics and physiological parameters will be performed before and after each condition. There will be a washout period of at 4 weeks between conditions. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05096702 -
Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in Brazil
|
||
| Recruiting |
NCT04073953 -
Primaquine Enantiomers in G6PD Deficient Human Volunteers
|
Phase 1 | |
| Completed |
NCT02434952 -
Safety and Tolerability of Low Dose Primaquine
|
Phase 4 | |
| Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
| Completed |
NCT04081272 -
Effect of G6PD Deficiency on Red Blood Cell Storage
|
||
| Completed |
NCT04146246 -
Comparative Evaluation of the FINDER Instrument and FINDER G6PD Cartridge in Adults and Neonates
|
||
| Recruiting |
NCT05026489 -
G6PD Deficiency in Infarction Patients in Shaanxi Province
|
||
| Terminated |
NCT03337152 -
Assessing a Risk Model for G6PD Deficiency
|
Phase 4 | |
| Completed |
NCT05753150 -
Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure After G6PD Testing in Thailand
|
||
| Completed |
NCT04010695 -
Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US
|
N/A | |
| Completed |
NCT04033640 -
Evaluation of a Diagnostic to Identify Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Brazil
|
N/A | |
| Completed |
NCT01931644 -
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
|
||
| Active, not recruiting |
NCT03529396 -
Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient Patients
|
Phase 2 | |
| Recruiting |
NCT05874271 -
Short Course Primaquine for the Radical Cure of P. Vivax - Papua New Guinea
|
N/A | |
| Recruiting |
NCT04088513 -
Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)
|
Phase 4 | |
| Not yet recruiting |
NCT05571748 -
Oxidative Stress, Carbohydrate Metabolism Disorders and G6PD Deficiency
|
N/A | |
| Completed |
NCT02937363 -
Effects of Alpha Lipoic Acid Supplementation in G6PD Deficient Individuals After Acute Exercise
|
N/A | |
| Recruiting |
NCT05879224 -
Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia
|
N/A | |
| Completed |
NCT04054661 -
Validation of a Diagnostic Test for Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Anti-coagulated Blood
|
N/A |